TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Dedicare Life Science AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
34,017
|
56,376
|
54,826 |
Financial expenses |
18
|
7
|
3 |
Earnings before taxes |
2,302
|
11,362
|
10,661 |
EBITDA |
2,158
|
11,377
|
10,683 |
Total assets |
12,281
|
17,778
|
18,114 |
Current assets |
12,281
|
17,778
|
18,079 |
Current liabilities |
3,350
|
8,686
|
9,611 |
Equity capital |
8,931
|
9,092
|
8,503 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
16
|
23
|
17 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.7%
|
51.1%
|
46.9% |
Turnover per employee |
2,126
|
2,451
|
3,225 |
Profit as a percentage of turnover |
6.8%
|
20.2%
|
19.4% |
Return on assets (ROA) |
18.9%
|
63.9%
|
58.9% |
Current ratio |
366.6%
|
204.7%
|
188.1% |
Return on equity (ROE) |
25.8%
|
125.0%
|
125.4% |
Change turnover |
-22,359
|
1,550
|
22,995 |
Change turnover % |
-40%
|
3%
|
72% |
Chg. No. of employees |
-7
|
6
|
3 |
Chg. No. of employees % |
-30%
|
35%
|
21% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.